Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Jun-24 8:00 PM View:  | Disc Medicine, Inc. (IRON) | 17-Jun-24 | Purchase | 222,223 | $36.00 | $8,000,030.00 | 24% 926.83K to 1.15M | |
| 07-Mar-24 4:40 PM View: | Disc Medicine, Inc. (IRON) | 05-Mar-24 | Private Sale | 26,157 | $73.50 | $1,922,540.00 | (3%) 952.99K to 926.83K | |
| 25-Jan-24 4:33 PM View: | Disc Medicine, Inc. (IRON) | 23-Jan-24 | Private Sale Duplicate | 102,500 | $67.65 | $6,934,120.00 | (10%) 1.06M to 952.99K | |
| 12-Jan-24 5:12 PM View: | Disc Medicine, Inc. (IRON) | 10-Jan-24 | Private Sale Duplicate | 20,000 | $64.00 | $1,280,000.00 | (2%) 1.08M to 1.06M | |
| 14-Dec-23 8:14 PM View: | Disc Medicine, Inc. (IRON) | 14-Dec-23 | Sale | 20,549 | $58.28 | $1,197,570.00 | (2%) 1.1M to 1.08M | |
| 14-Dec-23 8:14 PM View: | Disc Medicine, Inc. (IRON) | 13-Dec-23 | Sale | 3,548 | $60.00 | $212,865.00 | (< 1%) 1.1M to 1.1M | |
| 14-Dec-23 8:14 PM View: | Disc Medicine, Inc. (IRON) | 12-Dec-23 | Private Sale | 51,967 | $62.80 | $3,263,330.00 | (5%) 1.15M to 1.1M | |
| 17-Aug-23 4:13 PM View: | Disc Medicine, Inc. (IRON) | 15-Aug-23 | Private Sale Duplicate | 72,931 | $52.40 | $3,821,580.00 | (6%) 1.22M to 1.15M | |
| 03-Jun-21 8:07 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Jun-21 | Market Sale (Planned) | 17,489 | $26.28 | $459,611.00 | (< 1%) 2.25M to 2.23M | 2% |
| 14-Oct-20 4:54 PM View: | Akero Therapeutics, Inc. (AKRO) | 09-Oct-20 | Sale | 13,000 | $28.93 | $376,090.00 | (< 1%) 2.54M to 2.52M | |
| 25-Jun-19 6:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 24-Jun-19 | Conversion Duplicate | 3,704,860 | -- | -- | 100% 0 to 3.7M | |
| 25-Jun-19 6:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 24-Jun-19 | Purchase Duplicate | 270,000 | $16.00 | $4,320,000.00 | 7% 3.7M to 3.97M | |
| 24-May-17 4:38 PM View: | Editas Medicine, Inc. (EDIT) | 22-May-17 | Market Sale | 1,000,000 | $17.00 | $17,000,000.00 | (26%) 3.8M to 2.8M | (380%) |
| 08-Dec-16 5:07 PM View: | Editas Medicine, Inc. (EDIT) | 07-Dec-16 | Market Sale Duplicate | 75,000 | $15.82 | $1,186,500.00 | (2%) 3.87M to 3.8M | (409%) |
| 07-Dec-16 4:43 PM View: | Editas Medicine, Inc. (EDIT) | 06-Dec-16 | Market Sale | 50,000 | $15.87 | $793,500.00 | (< 1%) 7.84M to 7.79M | (408%) |
| 07-Dec-16 4:43 PM View: | Editas Medicine, Inc. (EDIT) | 05-Dec-16 | Market Sale | 80,000 | $15.74 | $1,259,200.00 | (1%) 7.92M to 7.84M | (412%) |
| 28-Nov-16 4:35 PM View: | Editas Medicine, Inc. (EDIT) | 23-Nov-16 | Market Sale | 21,480 | $15.71 | $337,451.00 | (< 1%) 4.02M to 4.0M | (413%) |
| 23-Nov-16 4:36 PM View: | Editas Medicine, Inc. (EDIT) | 22-Nov-16 | Market Sale | 12,819 | $15.77 | $202,156.00 | (< 1%) 4.04M to 4.02M | (411%) |
| 18-Nov-16 5:44 PM View: | Editas Medicine, Inc. (EDIT) | 16-Nov-16 | Market Sale | 30,830 | $16.30 | $502,529.00 | (< 1%) 4.07M to 4.04M | (394%) |
| 16-Nov-16 4:47 PM View: | Editas Medicine, Inc. (EDIT) | 15-Nov-16 | Market Sale | 30,865 | $16.57 | $511,428.00 | (< 1%) 12.26M to 12.23M | (386%) |
| 16-Nov-16 4:47 PM View: | Editas Medicine, Inc. (EDIT) | 14-Nov-16 | Market Sale | 58,035 | $17.16 | $995,881.00 | (< 1%) 12.32M to 12.26M | (369%) |
| 12-Sep-16 4:30 PM View: | Editas Medicine, Inc. (EDIT) | 08-Sep-16 | Market Sale Duplicate | 500,000 | $16.80 | $8,400,000.00 | (11%) 4.66M to 4.16M | (379%) |
| 09-Feb-16 6:00 PM View: | Editas Medicine, Inc. (EDIT) | 08-Feb-16 | Conversion Duplicate | 4,656,170 | -- | -- | 100% 0 to 4.66M | |
| 11-Feb-14 9:56 PM View: | Genocea Biosciences, Inc. (GNCA) | 10-Feb-14 | Conversion | 1,895,860 | -- | -- | 100% 0 to 1.9M | |
| 11-Feb-14 9:56 PM View: | Genocea Biosciences, Inc. (GNCA) | 10-Feb-14 | Purchase | 232,820 | $12.00 | $2,793,840.00 | 12% 1.9M to 2.13M |